Prognostic implications of tumor vascularity and its relationship to cytokeratin 19 expression in patients with hepatocellular carcinoma

Abdominal Imaging

Volumn 37, Issue 3, 2012, Pages 439-446

  Chung, Goh Eun ^a   Lee, Jeong Hoon ^b   Yoon, Jung Hwan ^b   Myung, Sun Jung ^b   Lee, Kyoungbun ^b   Jang, Ja June ^b   Lee, Jeong Min ^b   Kim, Se Hyung ^b   Suh, Kyung Suk ^b   Kim, Yoon Jun ^b   Lee, Hyo Suk ^b  

^a Seoul National University Hospital Healthcare System Gangnam Center   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Cytokeratin 19; Hepatocellular carcinoma; Prognosis; Recurrence; Tumor vascularity

Indexed keywords

BIOLOGICAL MARKER; CYTOKERATIN 19;

ADULT; ARTICLE; CANCER PATIENT; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TISSUE MICROARRAY; TUMOR RECURRENCE; TUMOR VASCULARIZATION;

CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; HUMANS; IOHEXOL; KERATIN-19; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84863726351     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9756-3     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-108
2. Lau WY, Lai EC (2008) Hepatocellular carcinoma: current management and recent advances. Hepatobiliary Pancreat Dis Int 7:237-257
3. Poon RT, Fan ST, Lo CM, et al. (2000) Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis Brelated cirrhosis. J Clin Oncol 18:1094-1101
4. Toyama T, Hiramatsu N, Yakushijin T, et al. (2008) A new prognostic system for hepatocellular carcinoma including recurrent cases: a study of 861 patients in a single institution. J Clin Gastroenterol 42:317-322
5. Sun M, Wu G, Li Y, et al. (2010) Expression profile reveals novel prognostic biomarkers in hepatocellular carcinoma. Front Biosci 2:829-840
6. Yang XR, Xu Y, Yu B, et al. (2010) High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma. Gut 59:953-962
7. Kim CK, Lim JH, Park CK, et al. (2005) Neoangiogenesis and sinusoidal capillarization in hepatocellular carcinoma: correlation between dynamic CT and density of tumor microvessels. Radiology 237:529-534
8. Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27-34
9. Takayasu K, Muramatsu Y, Mizuguchi Y, Ojima H (2007) CT Imaging of early hepatocellular carcinoma and the natural outcome of hypoattenuating nodular lesions in chronic liver disease. Oncology 72(suppl 1):83-91
10. Honda H, Tajima T, Taguchi K, et al. (2000) Recent developments in imaging diagnostics for HCC: CT arteriography and CT arterioportography evaluation of vascular changes in premalignant and malignant hepatic nodules. J Hepatobiliary Pancreat Surg 7:245-251
11. Yoon SH, Lee JM, So YH, et al. (2009) Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation. AJR Am J Roentgenol 193:W482-W489
12. Choi BI (2004) The current status of imaging diagnosis of hepatocellular carcinoma. Liver Transpl 10:S20-S25
13. Kim TK, Jang HJ, Wilson SR (2005) Imaging diagnosis of hepatocellular carcinoma with differentiation from other pathology. Clin Liver Dis 9:253-279
14. Kurokawa I, Urakawa Y, Senba Y, et al. (2006) Keratin profiles may differ between intraepidermal and intradermal invasive eccrine porocarcinoma. Oncol Rep 16:473-477
15. Wu PC, Fang JW, Lau VK, et al. (1996) Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Clinical and biological implications. Am J Pathol 149:1167-1175
16. Fanni D, Nemolato S, Ganga R, et al. (2009) Cytokeratin 20-positive hepatocellular carcinoma. Eur J Histochem 53:269-273
17. Yang XR, Xu Y, Shi GM, et al. (2008) Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection. Clin Cancer Res 14:3850-3859
18. Zhuang PY, Zhang JB, Zhu XD, et al. (2008) Two pathologic types of hepatocellular carcinoma with lymph node metastasis with distinct prognosis on the basis of CK19 expression in tumor. Cancer 112:2740-2748
19. Tralhao JG, Dagher I, Lino T, et al. (2007) Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients. Eur J Surg Oncol 33:746-751
20. Vogl TJ, Trapp M, Schroeder H, et al. (2000) Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center. Radiology 214:349-357
21. Choi JI, Lee JM, Kim SH, et al. (2009) Differentiating focal eosinophilic necrosis of the liver from hepatic metastases using unenhanced and portal venous phase computed tomographic imagings: results of univariate and multivariate statistical analyses. J Comput Assist Tomogr 33:705-709
22. Gao Q, Qiu SJ, Fan J, et al. (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586-2593
23. Uenishi T, Kubo S, Yamamoto T, et al. (2003) Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 94:851-857
24. Yeung YP, Lo CM, Liu CL, et al. (2005) Natural history of untreated nonsurgical hepatocellular carcinoma. Am J Gastroenterol 100:1995-2004
25. Tezuka M, Hayashi K, Kubota K, et al. (2007) Growth rate of locally recurrent hepatocellular carcinoma after transcatheter arterial chemoembolization: comparing the growth rate of locally recurrent tumor with that of primary hepatocellular carcinoma. Dig Dis Sci 52:783-788
26. Katyal S, Oliver JH, Peterson MS, et al. (2000) Prognostic significance of arterial phase CT for prediction of response to transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: a retrospective analysis. AJR 175:1665-1672
27. El-Assal ON, Yamanoi A, Soda Y, et al. (1998) Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 27:1554-1562
28. van Eyken P, Sciot R, van Damme B, et al. (1987) Keratin immunohistochemistry in normal human liver. Cytokeratin pattern of hepatocytes, bile ducts and acinar gradient. Virchows Arch A Pathol Anat Histopathol 412:63-72
29. Durnez A, Verslype C, Nevens F, et al. (2006) The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 49:138-151
30. van Sprundel RG, van den Ingh TS, Desmet VJ, et al. (2010) Keratin 19 marks poor differentiation and a more aggressive behaviour in canine and human hepatocellular tumours. Comp Hepatol 9:4
31. Imamura H, Matsuyama Y, Tanaka E, et al. (2003) Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol 38:200-207